XP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Acute Myeloid Leukemia

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Acute Myeloid Leukemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
Contact: Study coordinator (Junmin Li) · drlijunmin@126.com · +86-021-64370045

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of 14C-Bleximenib (Radiolabeled) in Participants With Acute Leukemia

Acute Lymphoblastic Leukemia · Acute Leukemias · Acute Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE1

Manchester, United Kingdom

225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome

Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia · Myelodysplastic Syndrome

Abroad (travel likely)RecruitingPHASE1

Duarte, United States

Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML

Acute Myeloid Leukemia · Acute Myeloid Leukemia, in Relapse

Abroad (travel likely)RecruitingPHASE1

Boston, United States

PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid Leukemia

Acute Myeloid Leukemia · Acute Promyelocytic Leukemia With PML-RARA

Abroad (travel likely)RecruitingPHASE1

Houston, United States